QURE investigation prompts Kessler Topaz Meltzer & Check, LLP to support uniQure N.V. (NASDAQ: —)
Investors who have suffered significant losses through their investments in uniQure N.V. (NASDAQ: QURE) are being advised to seek the assistance of Kessler Topaz Meltzer & Check, LLP. The legal firm is presently investigating potential violations of federal securities laws with the objective of representing investors of uniQure N.V. (NASDAQ: QURE) who have incurred financial losses.
In a recent development on November 3, 2025, uniQure made public a press release announcing that notification had been received from the FDA. The FDA communicated to uniQure that the data concerning AMT-130, an investigational gene therapy aimed at treating Huntington’s disease, did not offer adequate proof to back uniQure’s submission of a Biologics License Application (BLA). Specifically, uniQure disclosed that the FDA no longer believes that data from the Phase I/II studies for AMT-130 could serve as primary evidence for supporting a BLA submission. Consequently, the timing of the BLA submission for AMT-130 is now uncertain.
Following this news, the stock price of uniQure plummeted by more than 50%, dropping from a close of $67.69 on October 31, 2025, to a closing figure of $34.29 on November 3, 2025. These fluctuations in stock value have undoubtedly resulted in significant financial losses for investors holding uniQure N.V. (NASDAQ: QURE) securities.
UniQure investors who wish to delve deeper into this ongoing investigation are encouraged to engage with Kessler Topaz Meltzer & Check, LLP. By reaching out to the legal team, those impacted by the fluctuating fortunes of uniQure N.V. (NASDAQ: QURE) can seek guidance and potential avenues for legal recourse as the investigation continues.
Kessler Topaz Meltzer & Check, LLP (KTMC) boasts a formidable reputation in the domain of securities-fraud class actions and global investor protection in the United States. The law firm extends its services to individual investors as well as prominent institutions, including major pension funds, asset managers, and international investors. KTMC’s track record speaks volumes as the firm has been instrumental in spearheading some of the most substantial recoveries in securities litigation. Through its exceptional work, KTMC has garnered widespread recognition from peers and the legal fraternity, earning accolades such as The National Law Journal’s Plaintiff’s Hot List and Trailblazers in Plaintiffs’ Law, among others.
Operating on a global scale, Kessler Topaz Meltzer & Check, LLP has a presence in Pennsylvania and California. Those seeking additional information about the legal services provided by the firm can peruse their website at www.ktmc.com for insights into the comprehensive suite of offerings available. In the realm of securities litigation and global investor protection, Kessler Topaz Meltzer & Check, LLP remains a steadfast partner for investors navigating the complex landscape of financial markets.